Comparative outcome and prognostic factor analysis among MDS/AML patients with TP53 mutations, snps, and wild type

Abstract While variant TP53 is an adverse prognosis factor in myelodysplastic syndromes (MDS)/acute myeloid leukemia (AML), current clinical prognosis and variation feature analysis of TP53 alterations remain limited. We evaluated 333 MDS/AML patients with TP53 mutations, single nucleotide polymorph...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Xiaodi Yang, Zeyin Liang, Li Ji, Wei Liu, Bingjie Wang, Yuan Li, Jinping Ou, Xinan Cen, Hanyun Ren, Stefan Wuchty, Ziding Zhang, Yujun Dong
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2025-08-01
Edice:	Human Genomics
Témata:	TP53 Gene mutation MDS/AML Prognosis Hematopoietic stem cell transplantation
On-line přístup:	https://doi.org/10.1186/s40246-025-00792-z
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!